Home / Inspections / 1017161

FDA Inspection 1017161 — Mylan Laboratories Limited

Mylan Laboratories Limited — FEI 3007648351

The FDA completed an inspection of Mylan Laboratories Limited on April 18, 2017 in Bengaluru. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 18, 2017
Fiscal Year
2017
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Bengaluru (India)

Facility

Other inspections at this facility

  • 1204816 (NAI Fri Feb 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1119165 (VAI Fri Feb 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1089838 (VAI Mon May 13 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 966686 (VAI Wed Apr 13 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 912541 (OAI Fri Oct 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources